Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Kintara Therapeutics, Inc. (DMPI)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Net income | -3.3 | -3.5 | -4.6 | -5.4 | -5.4 | -5.9 | -6.0 | -6.7 |
| Change in working capital | -0.4 | -0.2 | -0.5 | 6.7 | -0.2 | 0.6 | 0.1 | 9.6 |
| Other | -0.4 | -0.2 | -0.5 | 6.7 | -0.2 | 0.6 | 0.1 | 9.6 |
| Other operating activities | 1.9 | 1.5 | -1.3 | -6.3 | 0.3 | 0.2 | 0.8 | -7.5 |
| Cash from operations | -1.8 | -2.2 | -6.4 | -5.0 | -5.2 | -5.1 | -5.1 | -4.7 |
| |
| Capital expenditures | 0.0 | 0.0 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Purchases of property and equipment | | | 0.9 | | | | | |
| Other cash from investing | | | -1.1 | 0.1 | | | | |
| Cash from investing | 0.0 | 0.0 | -0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Option exercises | | | | | | | | 0.0 |
| Other cash from financing | 0.0 | -0.1 | 1.9 | 7.9 | 0.0 | -0.2 | 13.9 | -0.5 |
| Cash from financing | 0.0 | -0.1 | 1.9 | 7.9 | 0.0 | -0.2 | 13.9 | -0.5 |
| |
| Free cash flow | -1.8 | -2.2 | -5.5 | -5.0 | -5.2 | -5.1 | -5.1 | -4.7 |
| Per share (diluted) | ($1.09) | ($1.32) | ($0.08) | ($0.10) | ($5.31) | ($5.26) | ($0.15) | ($0.18) |
| |
|